Get the Stockscreener App
1.21
0.83%
0.01
After Hours:
1.21
Citius Pharmaceuticals Inc stock is traded at $1.21, with a volume of 139.84K.
It is up +0.83% in the last 24 hours and down -6.92% over the past month.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.
See More
Previous Close:
$1.20
Open:
$1.2
24h Volume:
139.84K
Relative Volume:
0.14
Market Cap:
$20.58M
Revenue:
-
Net Income/Loss:
$-39.14M
P/E Ratio:
-0.2027
EPS:
-5.97
Net Cash Flow:
$-28.20M
1W Performance:
-1.63%
1M Performance:
-6.92%
6M Performance:
-23.90%
1Y Performance:
-90.65%
1-Day Range:
$1.18
$1.21
1-Week Range:
$1.16
$1.25
52-Week Range:
$0.65
$15.25
Citius Pharmaceuticals Inc Stock (CTXR) Company Profile
Name
Citius Pharmaceuticals Inc
Sector
Industry
Phone
(908) 967-6676
Address
11 COMMERCE DRIVE, CRANFORD, NJ
Compare CTXR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTXR
Citius Pharmaceuticals Inc
|
1.21 | 20.58M | 0 | -39.14M | -28.20M | -5.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Citius Pharmaceuticals Inc Stock (CTXR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-30-24 | Upgrade | D. Boral Capital | Hold → Buy |
| Nov-30-21 | Initiated | Maxim Group | Buy |
Citius Pharmaceuticals Inc Stock (CTXR) Latest News
Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement - PR Newswire
Citius Oncology raises $9 million in stock offering By Investing.com - Investing.com Australia
Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement - Nasdaq
Citius Oncology Raises $9 Mln Through Direct Offering And Private Placement - Nasdaq
Will Citius Pharmaceuticals Inc. benefit from rate cutsEarnings Miss & Fast Gain Swing Alerts - Lancaster City Council
Citius Oncology raises $9 million in stock offering - Investing.com
Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement - Benzinga
Can Citius Pharmaceuticals Inc. scale operations efficientlyInsider Selling & Short-Term High Return Ideas - Lancaster City Council
Citius Pharmaceuticals Inc. Moves Into Overbought Range Analysts Cautious2025 Valuation Update & Reliable Entry Point Alerts - beatles.ru
Is Citius Pharmaceuticals Inc. part of any major index2025 Macro Impact & Verified Entry Point Detection - classian.co.kr
Cannabis Stocks News - marketexclusive.com
Is Citius Pharmaceuticals Inc. a cyclical or defensive stock2025 Risk Factors & Safe Entry Zone Identification - beatles.ru
Does Citius Pharmaceuticals Inc. outperform in volatile markets2025 Key Highlights & Daily Profit Maximizing Tips - خودرو بانک
Citius Pharmaceuticals Inc. stock trend outlook and recovery pathJuly 2025 Rallies & Intraday High Probability Alerts - Newser
Is Citius Pharmaceuticals Inc. a momentum stockQuarterly Performance Summary & Expert Approved Trade Ideas - خودرو بانک
Will Citius Pharmaceuticals Inc. stock go up in YEARWeekly Market Summary & Accurate Entry/Exit Alerts - خودرو بانک
Volume spikes in Citius Pharmaceuticals Inc. stock – what they meanBond Market & Long-Term Safe Investment Plans - Newser
Can volume confirm reversal in Citius Pharmaceuticals Inc.2025 Price Momentum & Risk Controlled Daily Trade Plans - Newser
Should you hold or exit Citius Pharmaceuticals Inc. now2025 Biggest Moves & AI Driven Stock Reports - Newser
Is Citius Pharmaceuticals Inc. stock showing strong momentumEarnings Miss & Precise Entry and Exit Recommendations - خودرو بانک
Is Citius Pharmaceuticals Inc. building a consolidation baseCEO Change & Daily Stock Trend Reports - Newser
Why Citius Pharmaceuticals Inc. is moving todayWeekly Stock Report & High Yield Stock Recommendations - Newser
Using economic indicators to assess Citius Pharmaceuticals Inc. potentialIPO Watch & Safe Capital Preservation Plans - Newser
What the charts say about Citius Pharmaceuticals Inc. todayJuly 2025 Recap & High Accuracy Investment Entry Signals - Newser
Will Citius Pharmaceuticals Inc. see short term momentumInsider Buying & Weekly Watchlist for Consistent Profits - Newser
Analyzing net buyer seller activity in Citius Pharmaceuticals Inc.July 2025 Opening Moves & Weekly Momentum Stock Picks - Newser
Citius Oncology Deploys AI Platform to Amplify the Performance of Its Commercial Team Ahead of LYMPHIR Launch - 富途牛牛
Will Citius Pharmaceuticals Inc. stock recover after recent dropGap Down & Comprehensive Market Scan Insights - Newser
Chart based analysis of Citius Pharmaceuticals Inc. trendsEarnings Recap Report & Low Drawdown Investment Ideas - Newser
What is Citius Pharmaceuticals Inc. s debt to equity ratioJuly 2025 Intraday Action & Weekly High Return Stock Forecasts - خودرو بانک
Order flow analysis tools used on Citius Pharmaceuticals Inc.Global Markets & Expert Curated Trade Setup Alerts - Newser
Is Citius Pharmaceuticals Inc. showing insider buyingMarket Growth Report & Consistent Growth Stock Picks - خودرو بانک
Citius Pharmaceuticals Inc. stock trend forecastEarnings Beat & Weekly High Potential Stock Alerts - Newser
What data driven models say about Citius Pharmaceuticals Inc.’s futurePrice Action & Stepwise Entry and Exit Trade Signals - Newser
Will Citius Pharmaceuticals Inc. outperform the market2025 Price Momentum & Advanced Technical Signal Analysis - Newser
Citius Pharmaceuticals Soars 10.71% on Strategic Initiatives - AInvest
Citius Pharmaceuticals (CTXR) Soars 10.71% on Market Momentum - AInvest
Does Citius Pharmaceuticals Inc. qualify in momentum factor screeningJuly 2025 Setups & Safe Capital Allocation Plans - Newser
Citius Pharmaceuticals Inc. stock trendline breakdownGold Moves & Free Safe Entry Trade Signal Reports - Newser
Is Citius Pharmaceuticals Inc. trending in predictive chart modelsQuarterly Portfolio Report & Free Community Supported Trade Ideas - Newser
Citius Pharmaceuticals Inc Stock (CTXR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):